Author and year | Study type | Study population | Case severity n (%) | Antiviral agents - Number (%) started ≤48 h of symptoms | Antibiotics† n/N (%) pre n/N (%) on n/N (%) during admission | Any positive bacterial growth | Number (%) patients with S.pneumoniae and site of isolation | Number (%) with bacterial pneumonia - Method - Diff/no diff | ||
---|---|---|---|---|---|---|---|---|---|---|
ICU N | MV - type | Deaths | ||||||||
CDC (2009) [59] California, USA 4/09–5/09 | State-wide passive surveillance of notified cases / Hospitalized cases for > 24 h | N = 30 | 6/30 (20) | 4/30 (13.3) | 0/23 (0) 7 were still hospitalised | 15/30 (50) 5/30 (16.7) | 0 | 0/100 (0) | 0/100 (0) | 15/25 (60) CXR Non diff |
Jain [60] (2009) USA 4/09–6/09 | Notified cases from 24 state health departments to CDC / Hospitalized ≥24 h | N = 272 | 67/272 (24.6) | 42/272 (15.4) | 19/272 (7.0) | 200/268 (74.6) 78 (29.1) | 206/260 (79.2) - Pre: 30/198 - on: 117/198 | 3/182 (1.6) | 2/182 (1.1) 1 had positive lung tissue culture) 1/n urinary antigen test 1/n BAL fluid 0/n ET aspirate | - CXR 100/249 (40) (66 patients with bilateral infiltrates) 26 limited to 1 lobe, 6 limited to multiple lobes - not diff |
Louie [61] (2009) California, USA 4/09–8/09 | State-wide enhanced surveillance /Hospitalized or fatal all ages cases | N = 1088 | 340/1088 (31.3) | 193/297 (64.9) | 118/1088 (10.8) | 701/884 (79.3) - 357 (40.4) | NR | 46/1088 (4.2) | NR | 547/833 (65.7) - CXR/CT + pos bacterial culture(s) 46 - No diff |
Dhanoa [62] (2011) Malaysia 9/09–5/10 | Single-centre case series (retrospective)/ Hospitalised patients all ages | N = 50 | 9/50 (18.0) | 6/50 (12.0) | 2/50 (4.0) | 50/50 (100) | 49 (98.0) - Pre = 8 - On =41 | 14/45 (31.1) total 45 culture samples sent | 2/45 (4.4) site NR | 25/50 (50) -CXR + clinical opinion - No diff |
To [63] (2010) China 6/09–10/09 | Single-centre case series (retrospective)/ Hospitalized adult patients | N = 69 | 28/69 (40.6) | 26/69 (37.7) - NS | 13/69 (18.8) | 69/69 (100) | 37/69 (53.6) - On = 37 | 0/69 (0) | 0/69 (0) | 25/69 (36.2) CXR Non-diff |
Viasus [64] (2011) Spain 6/09–11/09 | Multicentre (13) case series (prospective)/ Hospitalized ≥24 h and had a chest radiograph done | N = 585 | 71/585 (12.1) | 52/585 (8.9) | 13/585 (2.2) | 545/585 (93.3) | 416/585 (71.7) | 45/585 (7.7) | 28/585 (4.8) | 234/585 (40) CXR non diff |
Palacios (2009) [42] Argentina 6/09–7/09 | Random sample specimens | N = 199 | 19/199 (9.5) | NR | 20/199 (10) | 96/120 (80) | 14/120 (11.7) | 152/199 (76.3) | 62/199 (31.1) | 152//199 (76) Culture pos |
Chitnis [6] | Wisconsin, hospital acute care PCR + cases | N = 252 | 59/252 (23.4) | 34/59 (58) Of tho9se cases admitted to ICU | 11/252 (4.3) | 215/250 (86) | 204/249 (81.9) | 19/241 (7.9) | NR | 123/229 (53.7) CXR non diff |
Riera [65] | 13 Hospitals in Spain | N = 585 | 71/585 (12.1) | 52/585 (8.9) | 13/585 (2.2) | 545/585 (93.1) 202/585 (34.5) | 316/585 (54) | 45/585 (7.7) (Sputum) | 2/585 (0.3) (1 sputum and 1 antigenuria positive | CXR infil 234/585 (40) Multilobarl infilt 135/585 (23.1) |
Semionov [66] | 147 cases with CXR results available in Montreal | N = 147 | 8/147 (5.4) | 6/147 (4.1) | 4/147 (2.7) | NR | NR | 21/42 (50) (of 42 radiological positive cases) | 5/21 (23.8) (of 21 positive bacterial cases) | 42/147 (28.6) cases positive CXR Non diff |
To [67] | 74 cases in Hong Kong | N = 74 | 28/74 (37.8) | 26/74 (35.1) | 2/74 (2.7) | 69/74 (93.2) | 52/74 (70.3) | 9/74 (12.2) bacterial positive 8 sputum 1 blood | 0/74 (0) | 9/74 (12.2) bacterial positive 8 sputum 1 blood Diff |
Masia [68] | Complicated hospital admitted cases in Spain > 18 years, out patients | N = 100 | 4/100 (4) | NR | 0/100 (0) | NR | NR | 14/100 (14) | 14/100 (14) Diff 8 urinary antigen pos, 2 isolated from blood and 4 from sputum | 14/100 (14) Diff |
Pecavar [69] | Hospitalized cases | N = 66 | 7/66 (10.6) | NR | NR | 62/64 (96.9) | 35/61 (57.4) | 5/63 (7.9) | 2/63 (3.2) | 29/57 (50.9) CXR Non diff |
Liu [70] | One hospital in China | N = 46 | NR | NR | NR | 46/46 (100) | 9/46 (19.6) | 9/15 (60) | NR | 44/46 (95.6) CXR or CT scan abnormal Non diff |
Nguyen (2010) [71] UK 4/09–9/09 | Multicentre (55) case series (retrospective)/ Hospitalized cases | N = 631 | 53/631 (8.4) | NR - IV = 21/631 (3.3) | 29/631 (4.6) | 474/631 (75.1) - NS | 366/631 (58) | 4/102 (3.9%) of cases with radiological pneumonia | 1/102 (0.9) sputum culture 0/102 (0) BC | 102/349 (29.2) - CXR - No diff |
Santa-Olalla Peralta [72] (2010) Spain 4/09–12/09 | National surveillance of severe cases (retrospective) / Hospitalized patients all ages (, in Spain | N = 3025 | 852/3025 (28.2) | 438/3.25 (14.5) | 200/3025 (6.6) | 2521/2779 (90.7) - 711/2020 (35.2) | NR | 292/957 (30.5, bacteria isolated not reported) | NR | NR |
Venkata [73] (2010) USA 5/09–12/09 | Single-centre case series (retrospective)/ Electronic medical records of hospitalized adult patients | N = 66 | 29/66 (43.9) | 23/66 (34.8) - IV = 17 (73.9) - NIV = 6 (26.1) | 5/66 (7.6) 4 more died after discharge from hospital | 60/66 (90.9) - NR | 14/ 29 (48.2) Bac culture pos | 3/29 (10.3), site NS | 14/29 (48.2) confirmed and 10/29 (34.5) probable bacterial pneumonia - NR - Diff | |
Jartti [74] | Cases with severe cases and CXR finding available, I hospital in Finland | N = 135 | 18/135 (13%) | 18/135 (13.3) | 3/135 (2.2) | NR | NR | 5/135 (3.7) Site not mentioned | 1 /135 (0.7) Isolated from Plural Fluid | 84/135 (62.2) |
Rizzo [75] | Sentinel sites, Italy | N = 1278 | NR | NR | NR | NR | NR | 33/1278 (2.6) | 0/1278 (0) | 271/1278 (21.2) Non-diff |
Kopel [76] | Til Aviv, cases in ICU and PICU | N = 17 | 17/17 (100) | NR | 7/17 (41.2) | NR | NR | 9/17 cases (52.9) (but likely nosocomial infection, so not included) | 0/17 (0) | NR |
D’Ortenzio [41] | ReUnion Island, all sites, included 785 reported cases, 282 hospitalized cases included here | N = 282 | 24/282 (8.5) | 15/282 (5.3) | 7/282 (2.5) | 92/171 (53.8) 39/163 (23.9) (within 48 h) | NR | NR | NR | 24/83 (28.9) (Confirmed and suspected) Sample not reported |
Dominguez-Cherit [77] | Critically ill, hospitalized in 6 hospital in Maxico | N = 58 | 58/58 (100) | 54/58 (93.1) | 24/ 58 (41.4) | 57/58 (98.3) | 52/58 (89.6) | 4/58 (6.9) | 0/58 (0) | NR |